On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.

 

 

 

On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
&nbsp;
&nbsp;
&nbsp;

Stay in the know with programs such as Viewpoint and Industry Insights in property, cryptocurrency, aviation, and shipping. 

We delve into the latest news, current events, and market updates to provide you with valuable insights into making informed financial decisions.

Stay in the know with programs such as Viewpoint and Industry Insights in property, cryptocurrency, aviation, and shipping. We delve into the latest news, current events, and market updates to provide you with valuable insights into making informed financial decisions.

Advertisement